This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Alan B. Bloch, MD, MPH; Esther Sumartojo, PhD; Kenneth G. Castro, MD
Centers for Disease Control and Prevention Atlanta, Ga

JAMA. 1994;272(6):436.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—The many public and private health care providers and outreach workers of New York State and NYC are to be congratulated for achieving a more than 10-fold increase in DOT for TB patients in NYC in just 2 years.¹ It is critical that this effort be sustained. While attributing any decline in secular trends to a specific intervention must be done cautiously, the role of DOT in the dramatic 15% decrease in reported TB cases from 1992 to 1993 (from 3811 to 3235) must be strongly considered. It will be important to further document their success by evaluating completion rates in patients with and without this intervention.

At the same time, the use of DOT in NYC was not the only intervention. It was part of an individualized patient treatment plan that also provided accessible services, a reliable source of medication, treatment in a variety of settings, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?